Diabetes Mellitus: all 11,090 studies

Page 85 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• VA Diabetes Prevention: Epidemiology of Pre-Diabetes and Implementation PilotWithdrawnNCT01671735Not applicable
• The Association Between Monocyte Subsets and Coronary Collateral Development in Diabetes MellitusCompletedNCT01671306
• Automated SMS-Based Appointment Validation ToolStatus unknownNCT01671189Early Phase 1
• Point of Service Diabetes Screening EvaluationCompletedNCT01669616
• A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug UseCompletedNCT01669473Not applicable
• Mechanisms of Glucose Counterregulation in Pancreatic Islet TransplantationCompletedNCT01668485Phase 4
• Improving Diabetes Through Lifestyle and SurgeryCompletedNCT01667783Phase 2/3
• Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes MellitusCompletedNCT01667185
• Telephone Counselling to Promote Physical Activity in Diabetes Mellitus PeopleCompletedNCT01666938Not applicable
• Short Term Closed-loop Glucose Control in Adults With Type 1 DiabetesCompletedNCT01666028Phase 2
• Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)StudyCompletedNCT01665989Not applicable
• Ovarian Ageing in Type 1 Diabetes MellitusCompletedNCT01665716
• A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 DiabetesCompletedNCT01665352Phase 2
• Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes MellitusCompletedNCT01663220
• Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompletedNCT01662921Phase 2
• Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 DiabetesCompletedNCT01661192Phase 2
• Diabetes Outcomes and Nurse Case Manager StudyCompletedNCT01659294Not applicable
• Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DMCompletedNCT01658501Phase 2
• Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands StudyCompletedNCT01657227Not applicable
• A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes MellitusWithdrawnNCT01655186Phase 2
• Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 DiabetesCompletedNCT01654341Not applicable
• Effect of Flavanol-rich Cocoa on Peripheral and Cerebral Blood Flow in Type 2 DiabetesCompletedNCT01654172Not applicable
• Comparative Effectiveness of Two Approaches to Diabetes Management in the UninsuredCompletedNCT01653951Not applicable
• Peking and Rotterdam on Mission to Reduce Coronary Artery DiseaseStatus unknownNCT01653119Not applicable
• Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 DiabetesCompletedNCT01650129Phase 3
• Safety and Efficacy of Insulin Aspart in Type 2 DiabetesCompletedNCT01649570Phase 4
• Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.CompletedNCT01649466Phase 4
• The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 DiabetesCompletedNCT01648244Not applicable
• Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DMCompletedNCT01648153Phase 2
• Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 DiabetesTerminatedNCT01647308Phase 2
• Diabetes Visual Function Supplement StudyCompletedNCT01646047Not applicable
• Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 DiabeticsCompletedNCT01645696Not applicable
• Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes MellitusCompletedNCT01645332Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of the Use of Ozone Versus Sunflower Oil in Treating Diabetic FootStatus unknownNCT01643967Phase 3
• Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to ClopidogrelStatus unknownNCT01643031Phase 4
• Impact of Self-care Education Program in Patients With Type 2 Diabetes in Primary Care in the Basque CountryCompletedNCT01642394Not applicable
• Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes MellitusStatus unknownNCT01642108Not applicable
• Resistance Training in Diabetic Elder PatientsCompletedNCT01638351Not applicable
• Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC SettingCompletedNCT01638299Phase 1
• GLP-1 and Non-exercise Activity Thermogenesis in RHZTerminatedNCT01638260Phase 4
• Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous WomenStatus unknownNCT01637727
• Evaluation of SCOUT DS Device in the Diagnosis of DiabetesStatus unknownNCT01634997
• Along-term Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT01634282Phase 3
• Type 1 Diabetes Mellitus Effect on Bone Mineral DensityCompletedNCT01633684
• Developing the Family Map: Looking at Communal CopingCompletedNCT01633021
• Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- MetforminCompletedNCT01632163Phase 3
• Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific RegionCompletedNCT01631084Not applicable
• Remote Monitoring of Diabetes in Pregnancy: a Feasibility StudyCompletedNCT01630759Not applicable
• Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 DiabetesCompletedNCT01630369Phase 4
• Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic MellitusCompletedNCT01629199Phase 3
• Study of Liraglutide in Individuals With Type 2 Diabetes Using InsulinTerminatedNCT01628445Phase 3
• French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic PatientsCompletedNCT01628341
• Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.Status unknownNCT01627509
• Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 SystemCompletedNCT01627210
• Long-term Use: CGM System Assessment in Adult Athletes With Diabetes MellitusCompletedNCT01627184
• Diabetes Adolescent and Family Group TherapyCompletedNCT01626586Not applicable
• The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 DiabetesCompletedNCT01626053Not applicable
• Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes MellitusCompletedNCT01621308
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese VolunteersCompletedNCT01620463Phase 1
• Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 DiabetesCompletedNCT01620424Phase 1
• Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes PatientsCompletedNCT01620125Early Phase 1
• Web-based Education for Diabetes Patients on Adaptable Insulin SchedulesCompletedNCT01619592Not applicable
• Pharmacoscintigraphic Investigation of NN9924 in Healthy Male SubjectsCompletedNCT01619345Phase 1
• A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 DiabetesCompletedNCT01618188Phase 1
• Aspirin Twice Daily in Diabetic Patients With Coronary Artery DiseaseCompletedNCT01617031
• Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 DiabetesCompletedNCT01615978Phase 1
• A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)TerminatedNCT01614782Phase 1
• Community Approach to Reduce the Risks of Diabetes After Gestational Diabetes MellitusCompletedNCT01613937Not applicable
• Diabetes Treatment With Glucobay in Combination With SulfonylureaCompletedNCT01613105
• Diabetes Treatment With Glucobay in Combination With MetforminCompletedNCT01612741
• Telecoaching of People With Type 2 Diabetes in Primary CareCompletedNCT01612520Not applicable
• Liraglutide in Type 1 DiabetesCompletedNCT01612468Phase 4
• A Phase 1 Study to Investigate the Mechanism of Action of IpragliflozinCompletedNCT01611363Phase 1
• REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for DiabetesCompletedNCT01611168Not applicable
• The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)CompletedNCT01610934Phase 2/3
• Developing and Testing an Implementation Strategy to Improve Perioperative Diabetes CareCompletedNCT01610674Not applicable
• Lifestyle Modification for Type 2 Diabetes Prevention in Overweight YouthCompletedNCT01610219Not applicable
• Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes MellitusCompletedNCT01609088Not applicable
• Ulcer Monitoring in Diabetes MellitusStatus unknownNCT01608425Phase 2
• A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 DiabetesCompletedNCT01607294Phase 2
• Biomarkers of Diabetic Retinopathy ProgressionCompletedNCT01607190
• Islet Transplant for Type 1 or Surgical DiabetesNo longer availableNCT01606475
• A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 DiabetesCompletedNCT01606397Phase 1
• A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT01606371Phase 1
• Cost Effectiveness and Quality of Life in Heart Failure Patients With DiabetesCompletedNCT01606085Not applicable
• Effect of Repaglinide on Postprandial Lipemia in Type 2 DiabetesCompletedNCT01605773Phase 4
• Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and AdolescenceCompletedNCT01605149
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery DiseaseCompletedNCT01604213Phase 4
• Type II Diabetes Mellitus in Patients Exposed to Pravastatin and ParoxetineCompletedNCT01602913
• Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 DiabetesCompletedNCT01602003Phase 3
• Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 DiabetesCompletedNCT01601990Phase 3
• Weight Loss Study for People With Type 2 DiabetesCompletedNCT01601574Phase 3
• Italian Diabetes and Exercise Study 2CompletedNCT01600937Not applicable
• Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in DiabetesActive, not recruitingNCT01600924
• The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 DiabetesCompletedNCT01600664Not applicable
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy SubjectsCompletedNCT01597713Phase 1
• Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric BandingTerminatedNCT01597531Phase 4
• Jordan Diabetes Microclinic ProjectCompletedNCT01596244Not applicable
• The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 DiabetesCompletedNCT01595789Phase 4
• The Clinical and Economic Impacts of e-Heath on DiabetesCompletedNCT01595269Not applicable

← Diabetes Mellitus overview